ABBV AbbVie Inc.
Stock · NYSE · United States · Healthcare · US00287Y1091
NowoTrade is an independent information site. It is not affiliated with, endorsed by or sponsored by AbbVie Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price
294.48 USD
-0.17%
52-week range
190.75 – 302.93
Dividend yield2.34%
Market cap522.6B
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 12 Nov 2026 21:01. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Next results
03 Feb 2027
in 82 days · 08:00 · estimate 3.88
Last results
3.82 vs 3.76 estimated
30 Oct 2026 · Beat +1.5%
Beat the estimate
9 of 12
0 missed · 3 in line · 2 beats in a row
Average surprise
+1.6%
reported against the estimate, last 12 quarters
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 03 Feb 2027 08:00 | 3.88 | — | — | Upcoming |
| 30 Oct 2026 07:00 | 3.76 | 3.82 | +1.5% | Beat |
| 31 Jul 2026 07:00 | 3.61 | 3.65 | +1.2% | Beat |
| 29 Apr 2026 07:00 | 2.67 | 2.65 | -0.8% | In line |
| 04 Feb 2026 07:00 | 2.65 | 2.71 | +2.2% | Beat |
| 31 Oct 2025 07:00 | 1.78 | 1.86 | +4.2% | Beat |
| 31 Jul 2025 07:00 | 2.91 | 2.97 | +2.1% | Beat |
| 25 Apr 2025 07:00 | 2.40 | 2.46 | +2.6% | Beat |
| 31 Jan 2025 07:00 | 2.12 | 2.16 | +1.9% | Beat |
| 30 Oct 2024 07:00 | 2.92 | 3.00 | +2.8% | Beat |
| 25 Jul 2024 07:00 | 2.66 | 2.65 | -0.4% | In line |
| 26 Apr 2024 07:00 | 2.26 | 2.31 | +2.4% | Beat |
| 02 Feb 2024 07:00 | 2.80 | 2.79 | -0.3% | In line |
| 27 Oct 2023 07:00 | 2.87 | 2.95 | +2.8% | Beat |
| 27 Jul 2023 07:00 | 2.81 | 2.91 | +3.6% | Beat |
| 27 Apr 2023 07:00 | 2.49 | 2.46 | -1.4% | Miss |
| 09 Feb 2023 07:00 | 3.58 | 3.60 | +0.7% | In line |
| 28 Oct 2022 07:00 | 3.57 | 3.66 | +2.7% | Beat |
| 29 Jul 2022 07:00 | 3.31 | 3.37 | +1.8% | Beat |
| 29 Apr 2022 07:00 | 3.14 | 3.16 | +0.6% | In line |
| 02 Feb 2022 07:00 | 3.28 | 3.31 | +0.8% | In line |
| 29 Oct 2021 07:00 | 3.22 | 3.33 | +3.5% | Beat |
| 30 Jul 2021 07:00 | 3.03 | 3.11 | +2.6% | Beat |
| 30 Apr 2021 07:00 | 2.83 | 2.95 | +4.3% | Beat |
| 03 Feb 2021 07:00 | 2.85 | 2.92 | +2.4% | Beat |
| 30 Oct 2020 07:00 | 2.77 | 2.83 | +2.3% | Beat |
| 31 Jul 2020 07:00 | 2.20 | 2.34 | +6.4% | Beat |
| 01 May 2020 08:00 | 2.25 | 2.42 | +7.7% | Beat |
| 07 Feb 2020 07:00 | 2.19 | 2.21 | +0.7% | In line |
| 01 Nov 2019 07:00 | 2.30 | 2.33 | +1.4% | Beat |
| 26 Jul 2019 07:00 | 2.21 | 2.26 | +2.5% | Beat |
| 25 Apr 2019 07:00 | 2.07 | 2.14 | +3.6% | Beat |
| 25 Jan 2019 07:00 | 1.93 | 1.90 | -1.7% | Miss |
| 02 Nov 2018 07:00 | 2.00 | 2.14 | +6.8% | Beat |
| 27 Jul 2018 07:00 | 1.97 | 2.00 | +1.3% | Beat |
| 26 Apr 2018 07:00 | 1.79 | 1.87 | +4.3% | Beat |
| 26 Jan 2018 07:00 | 1.43 | 1.48 | +3.7% | Beat |
| 27 Oct 2017 07:00 | 1.39 | 1.41 | +1.7% | Beat |
| 28 Jul 2017 07:00 | 1.40 | 1.42 | +1.5% | Beat |
| 27 Apr 2017 07:00 | 1.26 | 1.28 | +1.4% | Beat |
| 27 Jan 2017 07:00 | 1.20 | 1.20 | +0.3% | In line |
| 28 Oct 2016 07:00 | 1.20 | 1.21 | +0.5% | In line |
| 29 Jul 2016 07:00 | 1.20 | 1.26 | +5.0% | Beat |
| 28 Apr 2016 07:00 | 1.14 | 1.15 | +0.8% | In line |
| 29 Jan 2016 07:00 | 1.12 | 1.13 | +0.6% | In line |
| 30 Oct 2015 06:00 | 1.08 | 1.13 | +4.6% | Beat |
| 24 Jul 2015 07:00 | 1.06 | 1.08 | +1.8% | Beat |
| 23 Apr 2015 07:00 | 0.85 | 0.94 | +10.1% | Beat |
| 30 Jan 2015 07:00 | 0.86 | 0.89 | +3.5% | Beat |
| 31 Oct 2014 07:00 | 0.77 | 0.89 | +15.1% | Beat |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 61.2B | +8.6% | 4.2B | 6.9% | 2.37 | -0.8% | 17.8B |
| 2024 | 56.3B | +3.7% | 4.3B | 7.6% | 2.39 | -12.1% | 17.8B |
| 2023 | 54.3B | -6.4% | 4.9B | 9.0% | 2.72 | -59.0% | 22.1B |
| 2022 | 58.1B | — | 11.8B | 20.4% | 6.63 | — | 24.2B |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 09 Nov 2026 – 12 Nov 2026 In progress | 293.84 | 300.42 | 289.59 | 294.48 | +1.09% | 15,240,784 | |
| 02 Nov 2026 – 06 Nov 2026 | 290.38 | 302.93 | 281.07 | 291.31 | -1.21% | 35,658,600 | |
| 26 Oct 2026 – 30 Oct 2026 | 287.05 | 298.74 | 281.23 | 294.89 | +3.24% | 22,112,200 | |
| 19 Oct 2026 – 23 Oct 2026 | 284.23 | 290.98 | 278.01 | 285.64 | +0.08% | 24,543,200 | |
| 12 Oct 2026 – 16 Oct 2026 | 277.65 | 291.40 | 273.70 | 285.42 | +3.24% | 31,022,800 | 1.7300 |
| 05 Oct 2026 – 09 Oct 2026 | 261.27 | 277.60 | 260.29 | 276.47 | +5.19% | 27,909,400 | |
| 28 Sep 2026 – 02 Oct 2026 | 264.33 | 268.93 | 257.87 | 262.82 | -0.58% | 22,563,400 | |
| 21 Sep 2026 – 25 Sep 2026 | 263.07 | 269.39 | 261.23 | 264.34 | +0.14% | 15,663,600 | |
| 14 Sep 2026 – 18 Sep 2026 | 261.67 | 266.34 | 257.80 | 263.96 | +2.66% | 24,433,400 | |
| 08 Sep 2026 – 11 Sep 2026 | 251.84 | 259.61 | 246.77 | 257.12 | +0.26% | 18,141,500 | |
| 253 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- How Did AbbVie's Immunology Franchise Fare in Q3? (opens in a new tab) Zacks · 12 Nov 2026 16:56
- AbbVie Deal Altering The Investment Case For Nxera Pharma Stock (TSE:4565)? (opens in a new tab) Simply Wall St. · 12 Nov 2026 16:09
- The Zacks Analyst Blog Highlights NVIDIA, Walmart, AbbVie, Pioneer Bancorp and Aspira (opens in a new tab) Zacks · 12 Nov 2026 13:46
- Coca-Cola or AbbVie: The One Dividend Stock I’d Hold for the Next 20 Years (opens in a new tab) TIKR · 12 Nov 2026 10:27
- AbbVie (ABBV) Reports Positive Phase 3 QULIPTA Migraine Trial Results (opens in a new tab) Simply Wall St. · 12 Nov 2026 08:16
- Top Analyst Reports for NVIDIA, Walmart & AbbVie (opens in a new tab) Zacks · 11 Nov 2026 20:08
- ABBV Stock Rises More Than 4% in a Month: Time to Buy, Hold or Sell? (opens in a new tab) Zacks · 11 Nov 2026 15:39
- Can AbbVie (ABBV) Justify Its Valuation After Raised Guidance And Strong Results? (opens in a new tab) Simply Wall St. · 10 Nov 2026 22:12
- While pharma peers stumble, AbbVie defeated the patent cliff (opens in a new tab) Investing.com · 10 Nov 2026 10:23
- Zacks Investment Ideas feature highlights: Moderna, AbbVie, Eli Lilly and Merck (opens in a new tab) Zacks · 09 Nov 2026 09:20
- Is AbbVie Inc. (ABBV) the Best Healthcare Stock to Buy Following the 2026 Democratic Midterm Sweep? (opens in a new tab) Insider Monkey · 08 Nov 2026 15:43
- MarketBeat Week in Review – 11/2 - 11/6 (opens in a new tab) MarketBeat · 07 Nov 2026 12:00
- What Could Stall AbbVie Stock's Run? (opens in a new tab) Trefis · 07 Nov 2026 10:07
- Why Is AbbVie (ABBV) Spending $1.37 Billion On Pipeline And UK Research? (opens in a new tab) Simply Wall St. · 07 Nov 2026 07:11
- Pfizer vs. AbbVie: Higher Yield and Cheaper Valuation Give One the Clear Edge (opens in a new tab) Barchart · 07 Nov 2026 00:00
Headlines link to the original articles of the publishers shown; NowoTrade does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 294.98 USD
- Market cap
- 522.6B
- Dividend yield
- 2.34%
- 5-year average yield
- 3.40%
- Payout ratio
- 117%
- Last dividend
- 1.7300 USD · 15 Jan 2027
- Next ex-dividend date
- 15 Jan 2027
- Exchange
- NYSE
- Country
- United States
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Currency
- USD
Dividends
| Ex-dividend date | Per share |
|---|---|
| 15 Oct 2026 | 1.7300 USD |
| 15 Jul 2026 | 1.7300 USD |
| 15 Apr 2026 | 1.7300 USD |
| 16 Jan 2026 | 1.7300 USD |
| 8 older dividends: create a free account to see them | |
Why this score
Similar shares
Follow ABBV and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.